11th International Symposium on Biosimilar Medicines

GPA Conferences is organizing European Generics Association’s 11th International Symposium on Biosimilar Medicines, which will be held in London, UK between 25-26th of April 2013.

The event will start with a pre-symposium workshop focused on US biosimilar pathway and continue with the opening address of EGA president, Gudbjorg Edda Eggertsdottir in the afternoon of 25th April. This year’s event will focus on several important topics; highlights are listed below:

EGA SYMPOSIUM HIGHLIGHTS 2013
• Exploit the latest developments in the biosimilar field
• Get the IMS outlook on the biotechnology and biosimilars global market with a special focus on Europe
• Become familiar with the legislative developments regarding the Price Transparency Directive and its potential impact
• Hear the investor’s insights into the US and Asian markets
• Exchange views on the best practices around Europe supporting uptake of biosimilars in key markets
• Understand the myths and facts around biosimilars
• Get a detailed update directly from the EU and US regulators on the respective guidelines
• Join the discussion on global development and immunogenicity assessment for biosimilar monoclonal antibodies
• Identify the opportunities offered by biosimilars and the key points clinicians should know
• Get clarity regarding terminology of biosimilars, INN naming and traceability of biologicals

For full information, the website of the conference is: http://www.gpaconferences.com/bios.htm

Would you like to post an event on Biosimilar News?

Related posts:

1. 10th EGA International Symposium on Biosimilar Medicines
2. Global framework for biosimilars “is now crucial”
3. 11th Annual Biosimilars UK Conference
4. Biosimilar Drug Development World – Europe 2013
5. Biosimilars & Biobetters Congress 2013